95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.59%
Negative revenue growth while AEM stands at 0.80%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.62%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.52%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.52%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.05%
Share reduction more than 1.5x AEM's 0.24%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.11%
Diluted share count expanding well above AEM's 0.07%. Michael Burry would fear significant dilution to existing owners' stakes.
-44.76%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-6.99%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
31.55%
Positive FCF growth while AEM is negative. John Neff would see a strong competitive edge in net cash generation.
13.95%
10Y revenue/share CAGR under 50% of AEM's 29.83%. Michael Burry would suspect a lasting competitive disadvantage.
12.85%
5Y revenue/share CAGR under 50% of AEM's 46.63%. Michael Burry would suspect a significant competitive gap or product weakness.
42.63%
3Y revenue/share CAGR at 50-75% of AEM's 79.83%. Martin Whitman would question if the firm lags behind competitor innovations.
-5.57%
Negative 10Y OCF/share CAGR while AEM stands at 2.18%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
21.90%
Positive OCF/share growth while AEM is negative. John Neff might see a comparative advantage in operational cash viability.
82.91%
3Y OCF/share CAGR at 75-90% of AEM's 102.53%. Bill Ackman would press for improvements in margin or overhead to catch up.
-21.60%
Negative 10Y net income/share CAGR while AEM is at 201.12%. Joel Greenblatt sees a major red flag in long-term profit erosion.
59.10%
Below 50% of AEM's 121.47%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
290.73%
3Y net income/share CAGR 50-75% of AEM's 567.98%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
86.13%
10Y equity/share CAGR above 1.5x AEM's 9.86%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
18.37%
5Y equity/share CAGR at 75-90% of AEM's 21.57%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
14.03%
3Y equity/share CAGR similar to AEM's 14.06%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
323.53%
10Y dividend/share CAGR above 1.5x AEM's 93.05%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
190.02%
Similar 5Y dividend/share CAGR to AEM's 188.62%. Walter Schloss sees parallel philosophies in mid-term capital returns.
66.46%
Below 50% of AEM's 198.03%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-24.73%
Firm’s AR is declining while AEM shows 17.82%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
280.32%
Inventory growth well above AEM's 23.34%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.09%
Asset growth at 75-90% of AEM's 1.34%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
0.97%
BV/share growth above 1.5x AEM's 0.27%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-7.67%
We’re deleveraging while AEM stands at 0.24%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-36.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.